Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 10
265
Views
4
CrossRef citations to date
0
Altmetric
Short Communications

Production of isoquinoline alkaloids from the in vitro conserved Fumaria parviflora and their in vitro wound healing activity

, , , &
Pages 2575-2579 | Received 06 Nov 2020, Accepted 14 Mar 2021, Published online: 06 Apr 2021
 

Abstract

Fumaria parviflora Lam. is a rare herbaceous annual plant, with a well-known richness of isoquinoline alkaloids. It is threaten due to expansion on construction in the Mediterranean coastal region. We established callus culture protocol aiming at in vitro conservation of this plant. Murashige and Skoog medium fortified with a combination of 0.5 mg/l 1-naphthaleneacetic acid (NAA) and 1 mg/l 6-benzylaminopurine (BAP) showed optimal callus initiation. UPLC-MS/MS profiling revealed that calli induced on the tested media were able to produce isoquinoline alkaloids. Eight alkaloids were isolated from aerial parts of the cultivated plant and their cytotoxicity against Human skin fibroblast (HF) and wound healing activity using in vitro scratch assay were determined. Structural similarity between the isolated alkaloids enabled structure activity relationship (SAR) study. Sanguinarine displayed the potent activity compared to the other alkaloids. Iminium ion and methylenedioxy potentiated the activity.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.